Published in Nephrol Dial Transplant on February 01, 1998
Recovery of renal function in dialysis patients. BMC Nephrol (2003) 0.86
IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol (2000) 2.93
Extended resections for hilar cholangiocarcinoma. Ann Surg (1999) 2.93
Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. Cancer Res (2001) 2.12
Extreme hyponatremia of 87 mmol/l without neurologic complications in a severely hypovolemic patient. Am J Med (2000) 2.01
Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation. Am J Transplant (2009) 1.88
Plasma cortisol levels before and during "low-dose" hydrocortisone therapy and their relationship to hemodynamic improvement in patients with septic shock. Intensive Care Med (2000) 1.83
Total hepatectomy and liver transplantation as two-stage procedure. Ann Surg (1993) 1.83
Do patients with congenital hemiparesis and ipsilateral corticospinal projections respond differently to constraint-induced movement therapy? Dev Med Child Neurol (2008) 1.81
Expression of hypoxia-inducible transcription factors in developing human and rat kidneys. Kidney Int (2006) 1.80
Troponin T in patients with low grade or atypical angina. Identification of a high risk group for short- and long-term cardiovascular events. Eur Heart J (1998) 1.43
Permanent detrimental effect of nonimmunological factors on long-term renal graft survival: a parsimonious model of time-dependency. Transplantation (2000) 1.42
[Morphologic studies of the placentas of HIV-positive mothers]. Pathologe (1988) 1.41
Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med (1999) 1.32
Hepatitis C virus reinfection in allografts after orthotopic liver transplantation. Hepatology (1992) 1.13
Histologic observations in human hepatitis non-A, non-B. Hepatology (1982) 1.13
Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). J Hepatol (1990) 1.09
Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol (2001) 1.06
Bilateral emphysematous pyelonephritis caused by Candida infection. Am J Kidney Dis (1999) 1.06
Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis. Lancet (1989) 1.05
Erythropoietin in polycystic kidneys. J Clin Invest (1989) 1.03
'Low-dose' dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int (2006) 1.03
Effects of impaired renal function, hemodialysis, and peritoneal dialysis on the pharmacokinetics of mezlocillin. Antimicrob Agents Chemother (1980) 1.00
Tie2 receptor expression is stimulated by hypoxia and proinflammatory cytokines in human endothelial cells. Circ Res (2000) 1.00
Cortical neuromodulation by constraint-induced movement therapy in congenital hemiparesis: an FMRI study. Neuropediatrics (2007) 0.99
Ofloxacin in the treatment of urinary tract infection in renal transplant recipients. Infection (1988) 0.99
Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506. Transplantation (1994) 0.99
Lysine-specific cleavage of beta 2-microglobulin in amyloid deposits associated with hemodialysis. Kidney Int (1989) 0.98
Synthesis of C-X-C and C-C chemokines by human peritoneal fibroblasts: induction by macrophage-derived cytokines. Am J Pathol (2001) 0.97
An outbreak of hospital-acquired Pseudomonas aeruginosa infection caused by contaminated bottled water in intensive care units. Clin Microbiol Infect (2008) 0.97
In the queue for a cadaver donor kidney transplant: new rules and concepts in the Eurotransplant International Foundation. Nephrol Dial Transplant (2000) 0.97
Effect of glucose degradation products on human peritoneal mesothelial cell function. J Am Soc Nephrol (2000) 0.95
Botulinum toxin assessment, intervention and follow-up for paediatric upper limb hypertonicity: international consensus statement. Eur J Neurol (2010) 0.94
Distribution of hepatitis C virus genotypes in German patients with chronic hepatitis C: correlation with clinical and virological parameters. J Hepatol (1997) 0.94
Cyclophosphamide pulse therapy in Wegener's granulomatosis. Nephrol Dial Transplant (1991) 0.93
Left ventricular hypertrophy and diastolic dysfunction: their relation to coronary heart disease. Cardiovasc Drugs Ther (1995) 0.92
Development of the corticospinal system and hand motor function: central conduction times and motor performance tests. Dev Med Child Neurol (2000) 0.91
Viral dynamics of hepatitis C early after orthotopic liver transplantation: evidence for rapid turnover of serum virions. Hepatology (1996) 0.91
Prognostic value of cardiac troponin T and I elevations in renal disease patients without acute coronary syndromes: a 9-month outcome analysis. Nephrol Dial Transplant (1999) 0.91
K+ channels and the intracellular calcium signal in human melanoma cell proliferation. J Membr Biol (1996) 0.91
Treatment of chronic hepatitis C with interferon alpha: long-term follow-up and prognostic relevance of HCV genotypes. J Hepatol (1996) 0.90
Effect of the hemodialysis membrane on the inflammatory reaction in vivo. Clin Nephrol (2000) 0.90
Cytogenetic findings on eight follicular thyroid adenomas including one with a t(10;19). Cancer Genet Cytogenet (1989) 0.90
The value of immunocytochemical staining of lymph node aspirates in diagnostic cytology. Br J Haematol (1988) 0.89
Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic patients. Atherosclerosis (1983) 0.89
Methylphenidate enhances both intracortical inhibition and facilitation in healthy adults. Pharmacopsychiatry (2003) 0.88
Fast corticospinal system and motor performance in children: conduction proceeds skill. Pediatr Neurol (1998) 0.88
Antibodies anti-Shiga toxin 2 B subunit from chicken egg yolk: isolation, purification and neutralization efficacy. Toxicon (2011) 0.88
Single nephron hyperfiltration and proteinuria in a newly selected rat strain with superficial glomeruli. Ren Physiol (1986) 0.88
Kinetic interactions between azlocillin, cefotaxime, and cefotaxime metabolites in normal and impaired renal function. Clin Pharmacol Ther (1984) 0.88
Biocompatibility and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function. Kidney Int (1998) 0.88
Increases in oxygen tension stimulate expression of ICAM-1 and VCAM-1 on human endothelial cells. Am J Physiol (1999) 0.87
Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation. Transplantation (1994) 0.87
Tumour-like growth of parathyroid autografts in uraemic patients. Proc Eur Dial Transplant Assoc (1981) 0.87
Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus. J Hepatol (1996) 0.87
Cytokine pattern during rejection and infection after liver transplantation--improvements in postoperative monitoring? Transplantation (1996) 0.86
Acute renal failure after liver transplantation: incidence, etiology, therapy, and outcome. Transplant Proc (2006) 0.86
Green urine after motorcycle accident. Nephrol Dial Transplant (2000) 0.86
Endothelin-like immunoreactivity in the aqueous humour and in conditioned medium from cultured ciliary epithelial cells. Curr Eye Res (1992) 0.86
Inhibition of tumour necrosis factor production in endotoxin-stimulated human mononuclear leukocytes by the prostacyclin analogue iloprost: cellular mechanisms. Cytokine (1997) 0.86
Diltiazem increases blood concentrations of cyclized cyclosporine metabolites resulting in different cyclosporine metabolite patterns in stable male and female renal allograft recipients. Br J Clin Pharmacol (1996) 0.85
Botulinum toxin treatment of children with cerebral palsy - a short review of different injection techniques. Neurotox Res (2006) 0.85
Establishment and functional characterization of human peritoneal fibroblasts in culture: regulation of interleukin-6 production by proinflammatory cytokines. J Am Soc Nephrol (1996) 0.85
[Bile duct carcinoma in an adenoma in the anastomotic area after hepaticojejunostomy--a case report]. Z Gastroenterol (1997) 0.85
Low level of intracortical inhibition in children shown by transcranial magnetic stimulation. Neuropediatrics (2004) 0.85
Improving anemia by hemodialysis: effect of serum erythropoietin. Kidney Int (1980) 0.85
Electrogenic Na+-ascorbate cotransport in cultured bovine pigmented ciliary epithelial cells. Am J Physiol (1989) 0.84
Conversion to tacrolimus after liver transplantation. Transpl Int (1996) 0.84
Hypoxia-inducible factors and tubular cell survival in isolated perfused kidneys. Kidney Int (2006) 0.84
Electrophysiological properties of cultured human trabecular meshwork cells. Exp Eye Res (1994) 0.84
Botulinum toxin treatment in cerebral palsy: evidence for a new treatment option. J Neurol (2001) 0.84
Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial. Clin Transplant (1995) 0.84
[Clinical aspects and fine structure of papillary cancer. With special reference to morphological carcinogenesis]. Dtsch Med Wochenschr (1984) 0.83
Complication rate of pancreas retransplantation after simultaneous pancreas-kidney transplantation compared with pancreas after kidney transplantation. Transplant Proc (2007) 0.83
Malignancies in patients under long-term immunosuppression after kidney transplantation. Transplant Proc (1997) 0.83
GB virus C infection in patients with chronic hepatitis B and C before and after liver transplantation. Transplantation (1996) 0.83
Amelioration of anemia after kidney transplantation in severe secondary oxalosis. Clin Nephrol (2006) 0.83
Multiple drug resistance gene expression in human renal cell cancer is associated with the histologic subtype. Cancer (1992) 0.82
Prophylactic use of low-dose urodilatin for prevention of renal impairment following liver transplantation: a randomized placebo-controlled study. Clin Transplant (1997) 0.82
Clinical, morphologic, biochemical, and immunohistochemical aspects of dialysis-associated amyloidosis. ASAIO Trans (1987) 0.82
Recurrence-free survival after liver transplantation for small hepatocellular carcinoma. Transpl Int (1998) 0.82
The peritoneal fibroblast and the control of peritoneal inflammation. Kidney Int Suppl (1996) 0.82
Kinetics and characteristics of an acute phase response following cardiac arrest. Intensive Care Med (1999) 0.82
Recurrence of autoimmune hepatitis after liver transplantation. Transplant Proc (1999) 0.82
[Pharmacokinetics of azlocillin in impaired renal function and haemodialysis (author's transl)]. Arzneimittelforschung (1979) 0.82
Plasma levels of tumor necrosis factor (TNF) and soluble TNF receptors in kidney transplant recipients. Transplantation (1994) 0.82
Characterization of Cl-/HCO3- exchange in cultured bovine pigmented ciliary epithelium. Exp Eye Res (1988) 0.82
[Primary malignant intraluminal tumor of the aorta]. Langenbecks Arch Chir (1997) 0.81
High mortality from urothelial carcinoma despite regular tumor screening in patients with analgesic nephropathy after renal transplantation. Transpl Int (1996) 0.81
COL4A5 splice site mutation and alpha 5(IV) collagen mRNA in Alport syndrome. Kidney Int (1993) 0.81
Impaired insulin sensitivity as an underlying mechanism linking hepatitis C and posttransplant diabetes mellitus in kidney recipients. Am J Transplant (2009) 0.81
Parathyroid autografts--morphology and function: six years' experience with parathyroid autotransplantation in uremic patients. World J Surg (1984) 0.81
Female sex hormone receptor status in advanced hepatocellular carcinoma and outcome after surgical resection. Surgery (1997) 0.81
HLA-antigens in systemic lupus erythematosus (SLE). Arch Dermatol Res (1979) 0.81
Long-term outcome of 27 patients after combined liver-kidney transplantation. Transplant Proc (2001) 0.81
Single-dose kinetics of recombinant human erythropoietin after intravenous, subcutaneous and intraperitoneal administration. Preliminary results. Contrib Nephrol (1989) 0.81
Effect of the calcium channel blocker diltiazem on cyclosporine A blood levels and dose requirements. Transplant Proc (1988) 0.80
[L-arginine administration improves mucosal structure in the early phase of reperfusion of small intestine transplants]. Langenbecks Arch Chir Suppl Kongressbd (1998) 0.80